Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)
China flag China · Delayed Price · Currency is CNY
20.08
-0.51 (-2.48%)
May 26, 2026, 3:00 PM CST

SHA:603579 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,5991,5521,5751,8451,9862,586
Other Revenue
21.1121.1121.919.8718.5827.06
1,6201,5731,5971,8552,0052,613
Revenue Growth (YoY)
1.82%-1.50%-13.92%-7.47%-23.26%29.30%
Cost of Revenue
1,1321,0931,0951,2941,4761,913
Gross Profit
488.55480.28502.03561.3528.47699.91
Selling, General & Admin
311.64293.09266.32277.87280.34329.02
Research & Development
97.9593.380.180.1888.66119.21
Other Operating Expenses
18.4123.126.017.77.836.27
Operating Expenses
427.71409.76355.22364.86382.33460.41
Operating Income
60.8370.52146.82196.44146.14239.5
Interest Expense
-13.6-20.42-5.9-27.41-28.79-28.74
Interest & Investment Income
98.9871.1753.8864.1144.37104.76
Currency Exchange Gain (Loss)
-3.38-3.387.427.925.76-15.75
Other Non Operating Income (Expenses)
-4.370.173.06-7.2-27.66-58.25
EBT Excluding Unusual Items
138.46118.06205.27233.84159.82241.52
Gain (Loss) on Sale of Investments
35.241.14-6.14-16.2210.414.69
Gain (Loss) on Sale of Assets
1.51.730.7-0.950.151.31
Asset Writedown
-2.75-3.1-1.21-1.29-0.01-1.7
Legal Settlements
5.15.1----
Other Unusual Items
21.4921.511.3714.81915.13
Pretax Income
199184.42209.99230.19179.37260.96
Income Tax Expense
23.8134.4318.1926.8614.6532.93
Earnings From Continuing Operations
175.18150191.81203.33164.72228.03
Minority Interest in Earnings
1.320.710.14-0.63-0.498.3
Net Income
176.5150.7191.95202.71164.23236.34
Net Income to Common
176.5150.7191.95202.71164.23236.34
Net Income Growth
1.94%-21.49%-5.31%23.43%-30.51%22.45%
Shares Outstanding (Basic)
187182173173174176
Shares Outstanding (Diluted)
187182198173174182
Shares Change (YoY)
-4.42%-8.24%14.21%-0.18%-4.53%2.16%
EPS (Basic)
0.940.831.111.170.951.35
EPS (Diluted)
0.940.830.971.170.951.30
EPS Growth
6.66%-14.43%-17.09%23.65%-27.21%19.86%
Free Cash Flow
50.9862.9117.06254.69136.14196.45
Free Cash Flow Per Share
0.270.350.091.470.781.08
Dividend Per Share
0.5000.5000.6500.7690.3850.538
Dividend Growth
-23.08%-23.08%-15.50%100.00%-28.58%40.02%
Gross Margin
30.15%30.54%31.44%30.26%26.36%26.79%
Operating Margin
3.75%4.48%9.19%10.59%7.29%9.17%
Profit Margin
10.89%9.58%12.02%10.93%8.19%9.05%
Free Cash Flow Margin
3.15%4.00%1.07%13.73%6.79%7.52%
EBITDA
113.6124.14203.83256.39204.07292.8
EBITDA Margin
7.01%7.89%12.76%13.82%10.18%11.21%
D&A For EBITDA
52.7653.6157.0159.9657.9353.3
EBIT
60.8370.52146.82196.44146.14239.5
EBIT Margin
3.75%4.48%9.19%10.59%7.29%9.17%
Effective Tax Rate
11.97%18.67%8.66%11.67%8.17%12.62%
Revenue as Reported
1,6201,5731,5971,8552,0052,613
Advertising Expenses
-140.82115.31130.36133.74180.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.